BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 32591592)

  • 1. The β-adrenergic receptor antagonist propranolol offsets resistance mechanisms to chemotherapeutics in diverse sarcoma subtypes: a pilot study.
    Porcelli L; Garofoli M; Di Fonte R; Fucci L; Volpicella M; Strippoli S; Guida M; Azzariti A
    Sci Rep; 2020 Jun; 10(1):10465. PubMed ID: 32591592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propranolol Sensitizes Vascular Sarcoma Cells to Doxorubicin by Altering Lysosomal Drug Sequestration and Drug Efflux.
    Saha J; Kim JH; Amaya CN; Witcher C; Khammanivong A; Korpela DM; Brown DR; Taylor J; Bryan BA; Dickerson EB
    Front Oncol; 2020; 10():614288. PubMed ID: 33598432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The β-adrenoceptor antagonist, propranolol, induces human gastric cancer cell apoptosis and cell cycle arrest via inhibiting nuclear factor κB signaling.
    Liao X; Che X; Zhao W; Zhang D; Bi T; Wang G
    Oncol Rep; 2010 Dec; 24(6):1669-76. PubMed ID: 21042766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The adrenergic receptor antagonists propranolol and carvedilol decrease bone sarcoma cell viability and sustained carvedilol reduces clonogenic survival and increases radiosensitivity in canine osteosarcoma cells.
    Duckett MM; Phung SK; Nguyen L; Khammanivong A; Dickerson E; Dusenbery K; Lawrence J
    Vet Comp Oncol; 2020 Mar; 18(1):128-140. PubMed ID: 31778284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The past, present, and future of cytotoxic chemotherapy and pathway-directed targeted agents for soft tissue sarcoma.
    Ryan CW; Desai J
    Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infantile hemangiomas β
    Bassi A; Filippeschi C; Oranges T; Caporalini C; Pini A; Nardini P; Gentile RM; Filippi L
    Pediatr Res; 2022 Jan; 91(1):163-170. PubMed ID: 33654276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impairment of Hypoxia-Induced CA IX by Beta-Blocker Propranolol-Impact on Progression and Metastatic Potential of Colorectal Cancer Cells.
    Barathova M; Grossmannova K; Belvoncikova P; Kubasova V; Simko V; Skubla R; Csaderova L; Pastorek J
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33228233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective activation of beta3-adrenoceptors by octopamine: comparative studies in mammalian fat cells.
    Carpéné C; Galitzky J; Fontana E; Atgié C; Lafontan M; Berlan M
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):310-21. PubMed ID: 10344530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The beta adrenergic receptor antagonist propranolol alters mitogenic and apoptotic signaling in late stage breast cancer.
    Montoya A; Varela-Ramirez A; Dickerson E; Pasquier E; Torabi A; Aguilera R; Nahleh Z; Bryan B
    Biomed J; 2019 Jun; 42(3):155-165. PubMed ID: 31466709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of β-Adrenergic Receptors Improves CD8
    Daher C; Vimeux L; Stoeva R; Peranzoni E; Bismuth G; Wieduwild E; Lucas B; Donnadieu E; Bercovici N; Trautmann A; Feuillet V
    Cancer Immunol Res; 2019 Nov; 7(11):1849-1863. PubMed ID: 31527069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-adrenergic antagonists influence abdominal aorta contractility by mechanisms not involving β-adrenergic receptors.
    Hauzer W; Bujok J; Czerski A; Rusiecka A; Pecka E; Gnus J; Zawadzki W; Witkiewicz W
    Folia Biol (Krakow); 2014; 62(3):243-50. PubMed ID: 25403077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of non-selective β-blockers is associated with decreased tumor proliferative indices in early stage breast cancer.
    Montoya A; Amaya CN; Belmont A; Diab N; Trevino R; Villanueva G; Rains S; Sanchez LA; Badri N; Otoukesh S; Khammanivong A; Liss D; Baca ST; Aguilera RJ; Dickerson EB; Torabi A; Dwivedi AK; Abbas A; Chambers K; Bryan BA; Nahleh Z
    Oncotarget; 2017 Jan; 8(4):6446-6460. PubMed ID: 28031536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the Antinociceptive Effects and Binding Properties of Propranolol and Bupranolol Enantiomers.
    Martin LJ; Piltonen MH; Gauthier J; Convertino M; Acland EL; Dokholyan NV; Mogil JS; Diatchenko L; Maixner W
    J Pain; 2015 Dec; 16(12):1321-1333. PubMed ID: 26456674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-adrenergic antagonist propranolol inhibits mammalian cell lysosome spreading and invasion by Trypanosoma cruzi metacyclic forms.
    Macedo S; Rodrigues JPF; Schenkman S; Yoshida N
    Microbes Infect; 2017; 19(4-5):295-301. PubMed ID: 28111357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chronic application of propranolol on beta-adrenergic signal transduction in heart ventricles from myopathic BIO TO2 and control hamsters.
    Witte K; Schnecko A; Hauth D; Wirzius S; Lemmer B
    Br J Pharmacol; 1998 Nov; 125(5):1033-41. PubMed ID: 9846642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infantile hemangiomas, retinopathy of prematurity and cancer: a common pathogenetic role of the β-adrenergic system.
    Filippi L; Dal Monte M; Casini G; Daniotti M; Sereni F; Bagnoli P
    Med Res Rev; 2015 May; 35(3):619-52. PubMed ID: 25523517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An increase in murine skeletal muscle peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) mRNA in response to exercise is mediated by beta-adrenergic receptor activation.
    Miura S; Kawanaka K; Kai Y; Tamura M; Goto M; Shiuchi T; Minokoshi Y; Ezaki O
    Endocrinology; 2007 Jul; 148(7):3441-8. PubMed ID: 17446185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propranolol targets the contractility of infantile haemangioma-derived pericytes.
    Lee D; Boscolo E; Durham JT; Mulliken JB; Herman IM; Bischoff J
    Br J Dermatol; 2014 Nov; 171(5):1129-37. PubMed ID: 24720697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. beta2-adrenergic receptor-selective agonist clenbuterol prevents Fas-induced liver apoptosis and death in mice.
    André C; Couton D; Gaston J; Erraji L; Renia L; Varlet P; Briand P; Guillet JG
    Am J Physiol; 1999 Mar; 276(3):G647-54. PubMed ID: 10070041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Action and disposition of the β3-agonist nebivolol in the presence of inflammation; an alternative to conventional β1-blockers.
    Sanaee F; Jamali F
    Curr Pharm Des; 2014; 20(9):1311-7. PubMed ID: 23978104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.